Rocha Carolina Damas, Caetano Braulia Costa, Machado Alexandre Vieira, Bruna-Romero Oscar
Laboratory of Immunopathology, René Rachou Research Center, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.
Int Microbiol. 2004 Jun;7(2):83-94.
Infections by intracellular pathogens such as viruses, some bacteria and many parasites, are cleared in most cases after activation of specific T cellular immune responses that recognize foreign antigens and eliminate infected cells. Vaccines against those infectious organisms have been traditionally developed by administration of whole live attenuated or inactivated microorganisms. Nowadays, research is focused on the development of subunit vaccines, containing the most immunogenic antigens from the particular pathogen. However, when purified subunit vaccines are administered using traditional immunization protocols, the levels of cellular immunity induced are mostly low and not capable of eliciting complete protection against diseases caused by intracellular microbes. In this review, we present a promising alternative to those traditional protocols, which is the use of recombinant viruses encoding subunit vaccines as immunization tools. Recombinant viruses have several interesting features that make them extremely efficient at inducing immune responses mediated by T-lymphocytes. This cellular immunity has recently been demonstrated to be of key importance for protection against malaria and AIDS, both of which are major targets of the World Health Organization for vaccine development. Thus, this review will focus in particular on the development of new vaccination protocols against these diseases.
由病毒、某些细菌和许多寄生虫等细胞内病原体引起的感染,在大多数情况下,通过激活识别外来抗原并清除受感染细胞的特异性T细胞免疫反应得以清除。针对这些传染性生物体的疫苗传统上是通过接种全活减毒或灭活微生物来研发的。如今,研究集中在亚单位疫苗的开发上,亚单位疫苗包含特定病原体中最具免疫原性的抗原。然而,当使用传统免疫方案接种纯化的亚单位疫苗时,诱导的细胞免疫水平大多较低,无法引发针对细胞内微生物引起的疾病的完全保护。在这篇综述中,我们提出了一种有前景的替代传统方案的方法,即使用编码亚单位疫苗的重组病毒作为免疫工具。重组病毒具有几个有趣的特性,使其在诱导T淋巴细胞介导的免疫反应方面极其高效。最近已证明这种细胞免疫对于预防疟疾和艾滋病至关重要,而这两种疾病都是世界卫生组织疫苗研发的主要目标。因此,本综述将特别关注针对这些疾病的新疫苗接种方案的开发。